Castle Biosciences's 15min chart indicates KDJ Death Cross, bearish Marubozu pattern.

Castle Biosciences's 15-minute chart has triggered a KDJ Death Cross and a Bearish Marubozu at 08/18/2025 12:00. This indicates that the momentum of the stock price is shifting towards a downward trend and has the potential to further decrease. Sellers currently control the market, and this bearish momentum is likely to continue.

Castle Biosciences' stock price has shown signs of a significant downward trend, as indicated by a KDJ Death Cross and a Bearish Marubozu on August 18, 2025, at 12:00. This technical analysis suggests that the momentum of the stock price is shifting towards a bearish trend, potentially leading to further decreases in value.

The KDJ Death Cross, a reversal pattern, occurs when the K line crosses below the D line on the KDJ indicator. The Bearish Marubozu, a candlestick pattern, is characterized by a long body with no shadows, indicating strong selling pressure. Both of these indicators suggest that sellers currently control the market, and this bearish momentum is likely to continue.

On August 13, 2025, Derek J. Maetzold, President & Chief Executive Officer and Director at Castle Biosciences, sold 43,019 shares of Common Stock at a weighted average price of $19.504 per share, totaling $839,042 [1]. Following the transaction, Maetzold directly owns 69,683 shares and indirectly owns 261,372 shares through various trusts. The sale was executed under a Rule 10b5-1 plan adopted on November 11, 2024. This transaction may reflect Maetzold's view on the stock's future performance.

Investors should closely monitor Castle Biosciences' stock price and technical indicators to make informed decisions. The current market conditions suggest a cautious approach, as the stock appears to be in a downward trend.

References:
[1] https://www.tradingview.com/news/tradingview:2cf6a17818acc:0-castle-biosciences-ceo-derek-j-maetzold-sells-shares/